Skip to content

Development and Validation of an Intelligent Predictive Model for Supportive Care Needs in Patients with Hepatocellular Carcinoma: A Multicenter Study

Development and Validation of an Intelligent Predictive Model for Supportive Care Needs in Patients with Hepatocellular Carcinoma: A Multicenter Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125542
Enrollment
Unknown
Registered
2026-05-28
Start date
2026-05-28
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma (HCC)

Interventions

Retrospective Modeling Group:None

Sponsors

The First Affiliated Hospital of the Army Medical University of the People's Liberation Army of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.stage ?: Inclusion Criteria: 1.Age >=18years; 2.Hospitalized with a primary diagnosis of hepatocellular carcinoma (ICD-10: C22.0); 3.Complete or complementable records of the Hepatobiliary-Cancer Patient Comprehensive Needs Scale available in the medical record system; 4.Complete information on key clinical characteristics (e.g., tumor stage, treatment regimen). 2.stage ?: Inclusion Criteria: 1.Age >= 18 years; 2.Newly diagnosed or recurrent hepatocellular carcinoma confirmed by pathological or clinical criteria; 3.Conscious and alert, with the ability to provide informed consent and complete questionnaires; 4.Relatively stable physical condition as assessed by a physician.

Exclusion criteria

Exclusion criteria: 1.Exclusion Criteria: 1.Concurrent active malignancy other than hepatocellular carcinoma (except those cured for >5 years); 2.Already in hospice care or with an estimated life expectancy extremely short (<1 month) at the time of historical assessment; 3.Diagnosis of other primary hepatic malignancies other than hepatocellular carcinoma; 4.Concurrent participation in an interventional clinical trial that may systematically affect symptoms and needs. 2.Exclusion Criteria: 1.Presence of severe cognitive, psychiatric, or communication disorders that prevent reliable completion of assessments; 2.Critically ill or unstable condition (e.g., admitted to ICU, acute massive bleeding, estimated life expectancy < 1 week); 3.Unable to understand Chinese without a qualified interpreter; 4.Currently participating in another interventional study that has altering patient-reported outcomes as a primary endpoint; 5.The right to deem the patient unsuitable for participation for any reason that may be detrimental to the patient or affect the quality of the study.

Design outcomes

Primary

MeasureTime frame
Total score of supportive care needs ?The most significant dimension of unmet supportive care needs;Model performance metrics (e.g., R2, MAE AUC, F1-score);

Countries

China

Contacts

Public ContactQiu Yan

The First Affiliated Hospital of the Army Medical University of the People's Liberation Army of China

1146601225@qq.com+86 233 68765701

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026